Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine, Rituximab, and Lenalidomide Maintenance in CLL/SLL
NCT01754857Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2013
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by University of Wisconsin–Madison. Started Nov 2013; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT01754857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754857.